The New Normal<br />By Rev Shark<br />RealMoney.com Contributor<br />3/31/2010 9:01 AM EDT <br /><br />An ounce of performance is worth pounds of promises. <br />-- Mae West<br /><br />We wrap up the first quarter of 2010 today, and it is another good one for the bulls. It looks much like the last three quarters of 2009 and there doesn't seem to be any worry or concern that it won't continue. The market remains surprisingly buoyant and refuses to make it easy for those who keep looking to buy on pullbacks. I won't even mention how miserable it has been for the bears who have been fighting this action for so long. <br /><br />The current run since early February is a good example of how lopsided the action has been. We have had only three days where the market has pulled back more than 0.5%, and in each case we reversed back up almost immediately. Volume has been mediocre almost the whole time and we've seen few pockets of wild momentum. We have become more and more extended and it's becoming increasingly difficult to find entry points, yet the market refuses to rest. <br /><br />Although we have had numerous straight-up moves in this market over the past year, individual investors seem to have missed out on much of it. They actually have been withdrawing money the whole time and have never really come to embrace the market like they have during rallies in years past. <br /><br />There are two primary reasons for this. First many market players never were able to shake their pessimism about the overall economy and have been unable to embrace this optimistic action in the stock market. There has been a huge disconnect between the fast and easy recovery the stock market is enjoying and the struggling economy on Main Street, where the real estate and jobs markets are still trying to stabilize. <br /><br />The market has been driven not by individual investors, but by a flood of cheap cash created by the stimulus and bailout programs and by more and more computerized trading that attempt to put that cash to work. <br /><br />These factors have made for a market that has traded in ways that are quite different from what we have seen in the past. I've never heard from so many experienced and successful traders who are struggling to deal with this market. While they may be enjoying some profits, they have felt out of tune and have struggled to find trading methodologies that work well. <br /><br />Back in January when we pulled back rather sharply, I thought we were finally undergoing a change in market character. That proved to be dead wrong as we went straight back up in "V"-shaped fashion like we did so often last year. <br /><br />The old adage "The trend is your friend" has proved to be the best strategy by far. Unfortunately, many individual investors have had trust issues with this market and have never really embraced it. It is the toughest bull market I've ever seen, and it is going to continue to present some major challenges as we start the next quarter. <br /><br />Overseas markets were slightly positive but the euro is stronger and the dollar is weaker and that is helping to boast oil and commodities this morning. It is likely to be another slow day, but there will likely be some end-of-the-quarter position to provide a little volatility. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: LIWA +13.0%, IRE +12.0% (Bank of Ireland to raise capital; reports earnings - WSJ), FSII +5.1%, FUL +4.2%, IMMR +2.4% (CAE Healthcare acquires Immersion medical simulation product lines and licenses TouchSense technology), HON +2.3%, CELM +1.9%... Select metals/mining stocks trading higher: GG +1.8%, GOLD +1.5% (reports increase in reserves and resources in FY09 annual report), SLV +1.5%, NGG +1.3%, SLW +1.2%... Other news: ARQL +40.0% (announces results of Ph. 2 trial with ARQ 197 in NSCLC), IRE +11.4% (still checking), ATSG +9.1% (announces new long-term aircraft and operating agreements with DHL), ISIS +6.8% (ISIS Pharm and GSK collaborate on RNA Therapeutics for rare and infectious diseases), AIB +5.2% (up in sympathy with IRE), ORCT +3.4% (still checking), CLNE +2.5% (signs agreement with AT&T to provide CNG fueling stations to support AT&T's deployment of 8,000 CNG fleet vehicles), AIXG +2.0% (still checking), SYT +1.9% (Syngenta launches isopyrazam with first registration in the UK)... Analyst comments: OXGN +23.0% (initiated with a Buy at Roth), WNR +2.9% (initiated with an Outperform at Macquarie), UL +1.9% (upgraded to Buy from Neutral at BofA/Merrill), RIMM +0.3% (initiated with an Outperform at Exane BNP Paribas). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: ZOOM -11.8%, HEAT -10.1%, RAD -8.3%, APWR -6.5%, SAI -5.7%, LNDC -5.5%, ZZ -3.8%, CAGC -3.1%... Select financial related names showing weakness: DB -2.9%, MBI -1.7%, STD -1.7%, RF -1.2%, NBG -1.2% (Moody's downgrades National Bank of Greece to A2 from A1)... Select casino related stocks trading lower: MPEL -1.8%, LVS -1.7%, MGM -1.5%, WYNN -1.2%... Other news: ONP -10.9% (announces it has priced its public offering of 3 mln shares of common stock at $8.25/share), HHGP -8.5% (filed for and priced a 4.2 mln share common stock offering at $4.35/share), ENCO -7.3% (pulling back from this week's 100%+ surge higher), CTIC -6.7% ( to sell $20 mln of shares of Series 4 Preferred Stock and warrants to purchase common stock to three institutional investors), LINC -3.6% (announces public equity offering of 3.0 mln shares by a selling stockholder), MWE -3.5% (announces public offering of 4 mln common units), LTD -3.4% (trading ex dividend), CATM -2.1% (prices 7.0 mln common shares at $12.00/share), IOC -1.7% (mentioned negatively again by Fraud Discovery; highlights "court documents that reveal conflicting statements"), BA -1.4% (expects to recognize an income tax charge of ~$0.20 per share as a result of the recently enacted Patient Protection and Affordable Care Act ), VVUS -1.1% (announces termination of agreement for the development of Testosterone MDTS)... Analyst comments: PSYS -1.5% (downgraded to Underweight from Neutral at Piper Jaffray), MS -1.1% (ests cut at Keefe Bruyette).